Jan 29, 2018 13:31 pm UTC| Business
WARREN, N.J., Jan. 29, 2018 -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that enrollment in its Phase 3 INOvation-1 study evaluating INOpulse® in patients...
Jan 29, 2018 13:31 pm UTC| Business
NEW YORK, Jan. 29, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Children's Place,...
Gulf Resources Provides Updates on the Rectification of its Bromine Business
Jan 29, 2018 13:31 pm UTC| Business
SHOUGUANG, China, Jan. 29, 2018 -- Gulf Resources, Inc. (Nasdaq:GURE) ("Gulf Resources" or the "Company"), a leading manufacturer of bromine, crude salt, specialty chemical products, and natural gas in China, today...
Award Winning Capstone CHP Installation Surpasses 700,000 Operating Hours
Jan 29, 2018 13:31 pm UTC| Business
VAN NUYS, Calif., Jan. 29, 2018 -- Capstone Turbine Corporation (www.capstoneturbine.com) (Nasdaq:CPST), the world's leading clean technology manufacturer of microturbine energy systems, announced today that the...
Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and Executive Vice President
Jan 29, 2018 13:31 pm UTC| Business
NOVATO, Calif., Jan. 29, 2018 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that it has...
Jan 29, 2018 13:31 pm UTC| Business
EMERYVILLE, Calif., Jan. 29, 2018 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the closing of its previously announced underwritten public offering of its common stock. Adamas sold 3,000,000 shares of...
Jan 29, 2018 13:30 pm UTC| Business
SAN JOSE, Calif., Jan. 29, 2018 -- POET Technologies Inc. (“POET”) (OTCQX:POETF) (TSX Venture:PTK), a designer, developer and manufacturer of optoelectronic devices, including light sources, passive wave guides and...